Loncar Cancer Immunotherapy ETF
ALTAR
Score™
-3.4% info Recommen-
dation
AVOID
2020E    2021E
P/E
ratio
-17.0x P/Sales
ratio
13.4x
P/BV
ratio
7.2x Div.
yield
0.8%


  • Description
  • Performance
  • Comps
  • premium Fundamentals
  • premium Valuation
  • premium Rating
This fund tracks the Loncar Cancer Immunotherapy Index, an equal-weighted index of companies currently producing or in clinical trials for cancer immunotherapy drugs.

FUND BASICS
Category US Equities
Fund Sponsor US Bancorp
Website www.loncarfunds.com/
Inception date Oct 13, 2015
Assets (mns) $42
Currency USD
Expense ratio 79 bp
Distributions Annually

FUND STRUCTURE
Regulation Open-End Investment Company
Custodian
Weighting Equal
Index replication
Uses derivatives No
Options available No

SECTOR BREAKDOWN

 


CONSTITUENT BREAKDOWN
No. of constituents 26
Wgt avg mkt cap (mns) $25,538
Large cap (>$10bn) 21.2%
Mid cap ($2-10bn) 38.5%
Small cap (<$2bn) 40.3%
Developed mkts 100.0%
Emerging mkts 0.0%

TOP TEN HOLDINGS
MODERNA, INC. 11.5 %
ALLOGENE THERAPEUTICS, INC. 6.0 %
FATE THERAPEUTICS INC 5.9 %
REGENERON PHARMACEUTICALS 5.7 %
ARGENX SE ADR 4.8 %
IOVANCE BIOTHERAPEUTICS INC 4.4 %
Y-MABS THERAPEUTICS, INC. 4.0 %
ASTRAZENECA PLC-SPONS ADR 4.0 %
GILEAD SCIENCES INC 4.0 %
CELLECTIS SA SPONSORED ADR 4.0 %
Total 54.1 %

TOP COUNTRY EXPOSURE
UNITED STATES 65.5 %
BRITAIN 7.3 %
NETHERLANDS 4.8 %
FRANCE 4.0 %
SWITZERLAND 3.4 %
CHINA 3.2 %
GERMANY 3.1 %
CANADA 3.1 %



HISTORICAL PERFORMANCE info

  Custom date range Compare to  
  thru


Standardized Annual Returns (thru May 31)
Year-to-date 1 year 5 years 10 years Since Incep.
13.0% 36.8% -- -- -0.5%

Market Correlations
versus... Beta R-squared
S&P500 1.19 39%
MSCI EAFE 1.11 29%
MSCI Emg. Mkts. 0.96 33%

Technical Indicators
Recent close $26.06
30d moving avg. $25.09
Annualized volatility 32.3%
Short interest (ETF) 1.2%
Relative strength (RSI) 58

Liquidity measures
Avg. volume (thou.) 23
Turnover 1.4%
Bid/Ask (% of price) 0.42%
ADV underlying (mns) $7,598

Distributions


FINDING ALTERNATIVE FUNDS

Below is a list of 99 potential alternatives to the Loncar Cancer Immunotherapy ETF ETF based on the alternatives' overlap in portfolio holdings with CNCR. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker: CNCR Expense: 79 bp ALTAR Score™: -3.4%


ALTERNATIVE ETFs BASED ON OVERLAP WITH CNCR
Ticker Fund
Name
Overlap1
vs CNCR
(%)
Expense
ratio
(bp)
Savings
vs CNCR
(bp)
ALTAR
Score™
(%)
ALTAR
vs CNCR
(%)
IDNA iShares Genomics Immunology & Healthcare ETF 33.2 47 32 -2.6 +0.8
BBH VanEck Vectors Biotech ETF 19.0 35 44 3.7 +7.2
IEIH iShares Evolved U.S. Innovative Healthcare ETF 16.7 18 61 4.0 +7.4
IBB iShares NASDAQ Biotechnology ETF 16.6 47 32 0.4 +3.8
BBC Virtus LifeSci Biotech Clinical Trials ETF 15.6 79 0 -1.0 +2.4
XBI SPDR S&P BIOTECH ETF 14.2 35 44 -3.9 -0.4
ARKG ARK Genomic Revolution Multi-Sector ETF 13.2 75 4 0.0 +3.4
GNOM Global X Genomics & Biotechnology ETF 13.1 68 11 -3.6 -0.2
PJP Invesco Dynamic Pharmaceuticals ETF 12.7 56 23 11.1 +14.5
GDNA Goldman Sachs Motif Human Evolution ETF 12.4 50 29 0.3 +3.7
FBT First Trust NYSE Arca Biotechnology Index Fund 12.2 57 22 -1.0 +2.5
BTEC Principal Healthcare Innovators Index ETF 11.7 42 37 -2.5 +0.9
IYH iShares U.S. Healthcare ETF 10.6 43 36 6.1 +9.5
PPH VanEck Vectors Pharmaceutical ETF 10.4 36 43 10.1 +13.5
XLV Health Care Select Sector SPDR Fund 10.2 13 66 7.0 +10.5
FHLC Fidelity MSCI Health Care Index ETF 9.9 8 71 5.6 +9.1
VHT Vanguard Health Care Index Fund 9.9 10 69 5.5 +8.9
XPH SPDR S&P Pharmaceuticals ETF 9.8 35 44 4.8 +8.2
SBIO ALPS Medical Breakthroughs ETF 9.4 50 29 -1.2 +2.2
PBE Invesco Dynamic Biotechnology & Genome ETF 9.3 57 22 -1.0 +2.4
JHMH John Hancock Multifactor Healthcare ETF 9.3 40 39 6.0 +9.4
PTH Invesco DWA Healthcare Momentum ETF 8.4 60 19 -2.6 +0.8
AADR WCM/BNY Mellon Focused Growth ADR ETF 8.3 110 -31 3.5 +6.9
IXJ iShares Global Healthcare ETF 8.2 46 33 6.2 +9.7
HELX Franklin Genomic Advancements ETF 8.0 50 29 -1.8 +1.6
FXH First Trust Health Care AlphaDEX Fund 8.0 62 17 4.4 +7.9
TECB iShares US Tech Breakthrough Multisector ETF 7.7 40 39 4.1 +7.6
DGRW WisdomTree U.S. Quality Dividend Growth Fund 7.7 28 51 6.5 +9.9
AIEQ AI Powered Equity ETF 7.7 87 -8 3.4 +6.8
LNGR Global X Longevity Thematic ETF 7.3 50 29 3.0 +6.5
NULV Nuveen ESG Large-Cap Value ETF 6.9 35 44 7.3 +10.7
FTXH First Trust Nasdaq Pharmaceuticals ETF 6.4 60 19 7.2 +10.6
DURA VanEck Vectors Morningstar Durable Dividend ETF 6.4 29 50 6.8 +10.2
IHE iShares U.S. Pharmaceuticals ETF 6.4 42 37 5.3 +8.7
MOAT VanEck Vectors Morningstar Wide Moat ETF 6.2 49 30 5.9 +9.3
RYH Invesco S&P 500 Equal Weight Health Care ETF 6.1 40 39 6.3 +9.8
IPO Renaissance IPO ETF 6.0 60 19 -6.2 -2.8
DHS WisdomTree U.S. High Dividend Fund 5.9 38 41 8.2 +11.7
FTCS First Trust Capital Strength ETF 5.6 60 19 4.9 +8.3
VFMV Vanguard U.S. Minimum Volatility ETF 5.5 13 66 3.8 +7.2
QDIV Global X S&P 500 Quality Dividend ETF 5.5 20 59 8.1 +11.5
JKD iShares Morningstar Large-Cap ETF 5.3 20 59 5.8 +9.2
SPDV AAM S&P 500 High Dividend Value ETF 5.3 29 50 10.3 +13.8
SDG iShares Sustainable MSCI Global Impact ETF 5.2 49 30 6.1 +9.5
RBUS Nationwide Risk-Based U.S. Equity ETF 5.1 30 49 5.1 +8.5
SPHQ Invesco S&P 500 Quality ETF 5.0 15 64 5.1 +8.5
OUSA O'Shares FTSE US Quality Dividend ETF 4.9 48 31 5.7 +9.1
VYM Vanguard High Dividend Yield Index ETF 4.8 6 73 7.1 +10.5
ECOZ TrueMark ESG Active Opportunities ETF 4.8 58 21 4.5 +7.9
HDIV QRAFT AI-Enhanced U.S. High Dividend ETF 4.8 75 4 6.0 +9.4
MTUM iShares Edge MSCI USA Momentum Factor ETF 4.6 15 64 4.8 +8.3
HTEC ROBO Global Healthcare Technology & Innovation ETF 4.6 68 11 0.5 +3.9
LVHD Legg Mason Low Volatility High Dividend ETF 4.5 27 52 8.4 +11.8
AUSF Global X Adaptive U.S. Factor ETF 4.4 27 52 7.8 +11.3
STLV iShares Factors US Value Style ETF 4.3 25 54 7.7 +11.1
SPGP Invesco S&P 500 GARP ETF 4.3 35 44 7.0 +10.5
FVAL Fidelity Value Factor ETF 4.3 29 50 8.0 +11.4
FPX First Trust US IPO Index Fund 4.2 59 20 4.2 +7.6
SDOG ALPS Sector Dividend Dogs ETF 4.1 40 39 9.7 +13.1
DVP Deep Value ETF 4.0 59 20 14.8 +18.2
UTRN Vesper U.S. Large Cap Short-Term Reversal Strategy ETF 4.0 75 4 5.4 +8.9
MGV Vanguard Mega Cap Value ETF 3.7 7 72 7.0 +10.4
DGRO iShares Core Dividend Growth ETF 3.7 8 71 6.4 +9.8
SCHV Schwab U.S. Large-Cap Value ETF 3.7 4 75 6.9 +10.3
DTN WisdomTree U.S. Dividend ex-Financials Fund 3.6 38 41 7.7 +11.1
FCPI Fidelity Stocks for Inflation ETF 3.6 29 50 6.7 +10.2
FLQL Franklin LibertyQ U.S. Equity ETF 3.6 15 64 6.2 +9.7
VFMO Vanguard U.S. Momentum Factor ETF 3.5 13 66 2.1 +5.5
RAFE PIMCO RAFI ESG U.S. ETF 3.5 29 50 7.5 +10.9
GBDV Global Beta Smart Income ETF 3.5 29 50 11.4 +14.8
FFTY Innovator IBD 50 ETF 3.4 80 -1 3.6 +7.0
ARKK ARK Innovation ETF 3.4 75 4 -3.2 +0.2
USDY Pacific Global US Equity Income ETF 3.3 29 50 7.5 +10.9
SUSL iShares ESG MSCI USA Leaders ETF 3.3 10 69 5.4 +8.8
USSG Xtrackers MSCI USA ESG Leaders Equity ETF 3.3 10 69 5.4 +8.9
QUAL iShares MSCI Usa Quality Factor ETF 3.3 15 64 5.4 +8.8
FTHI First Trust High Income ETF 3.3 85 -6 5.4 +8.8
DLN WisdomTree U.S. LargeCap Dividend Fund 3.3 28 51 6.3 +9.7
QQXT First Trust Nasdaq-100 Ex-Technology Sector Index Fund 3.3 60 19 3.5 +7.0
SCHD Schwab U.S. Dividend Equity ETF 3.3 6 73 7.2 +10.7
VTV Vanguard Value Index Fund 3.2 4 75 7.1 +10.6
TTAC TrimTabs Float Shrink ETF 3.2 59 20 3.6 +7.0
XRLV Invesco S&P 500 ex-Rate Sensitive Low Volatility ETF 3.2 25 54 5.9 +9.3
SZNE Pacer CFRA-Stovall Equal Weight Seasonal Rotation ETF 3.2 60 19 6.2 +9.6
RNDV US Equity Dividend Select ETF 3.2 50 29 7.4 +10.9
CHNA Loncar China BioPharma ETF 3.2 79 0 3.7 +7.1
DSI iShares MSCI KLD 400 Social ETF 3.2 25 54 5.2 +8.7
PWV Invesco Dynamic Large Cap Value ETF 3.1 55 24 8.0 +11.4
VSMV VictoryShares US Multi-Factor Minimum Volatility ETF 3.1 35 44 6.6 +10.1
DJD Invesco Dow Jones Industrial Average Dividend ETF 3.1 7 72 6.5 +9.9
HDV iShares Core High Dividend ETF 3.1 8 71 6.4 +9.9
SDGA Impact Shares Sustainable Development Goals Global ETF 3.1 75 4 5.4 +8.8
DIVO Amplify YieldShares CWP Dividend & Option Income ETF 3.1 49 30 4.8 +8.2
PAWZ ProShares Pet Care ETF 3.1 50 29 2.5 +6.0
NACP Impact Shares NAACP Minority Empowerment ETF 3.1 75 4 4.5 +7.9
CHGX Change Finance U.S. Large Cap Fossil Fuel Free ETF 3.1 49 30 5.4 +8.8
EDOW First Trust Dow 30 Equal Weight ETF 3.1 50 29 5.7 +9.1
SPLV Invesco S&P 500 Low Volatility ETF 3.1 25 54 5.7 +9.1
USMC Principal U.S. Mega-Cap Multi-Factor Index ETF 3.1 12 67 4.9 +8.3

1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

  2015 2016 2017 2018 2019 2020E 2021E
Sales per share ** ** ** ** ** ** **
Earnings per share ** ** ** ** ** ** **
Dividends per share info ** ** ** ** ** ** **
Book value per share ** ** ** ** ** ** **

 

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est. **%   Debt-to-equity **x
Asset turnover **%   Assets-to-equity **x

Return on equity

Revision activity*
*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS
  2019 2020E 2021E
Price-to-sales ** ** **
Price-to-earnings ** ** **
Price-to-cash flow ** ** **
Price-to-growth ** ** **
Price-to-book value ** ** **
Yield ** ** **

Historical valuation trends

Forward
multiple:
Loncar Cancer Immunotherapy ETF
Relative
to:
S&P500 MSCI EAFE MSCI Emg. Mkts. Other ETF:

AVOID

Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant.

ALTAR Score™


Calculation of ALTAR Score™
Avg. Return on Equity -26.7 %
Divided by: Fwd. P/BV 10.1 x
Less: Expense ratio 79 bp
Equals: ALTAR Score -3.4 %
info More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
COMPOSITE
RATING
1.26 CATEGORY
AVERAGE
1.53
 
The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale:

BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.

Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
 

 

See RATING tab for calculation of ALTAR Score™
Risk & reward. Uses std. dev. as proxy for risk, ALTAR Score™ for return forecast.
Dividends paid by constituents to the fund. May differ from actual distributions to shareholders due to constituent changes, timing issues or other factors.
Monthly returns based on changes in price plus dividends. May differ from daily returns reported by funds. See below for standardized returns.